Douglas Colby
Impact in
- Molecular Biology top 1%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Renal and related cancers
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Aging top 5%
Papers in
- Aging 1
-
- Pluripotent Stem Cells Research 14
- CRISPR and Genetic Engineering 14
- Renal and related cancers 4
- Epigenetics and DNA Methylation 3
- Co-authors
- Ian ChambersMorag RobertsonJennifer NicholsAustin SmithSusan TweedieSonia LeeBianca NijmeijerKen Jones
- Journals
- The EMBO Journal (4 papers)Cell stem cell (2 papers)Biochemical Journal (1 paper)Life Science Alliance (1 paper)FEBS Letters (1 paper)
- Partner nations
- United KingdomSingaporeJapan
In The Last Decade
Douglas Colby
15 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 4.1k
- Aging 58
- Genetics 248
- Developmental Neuroscience 80
- Genetics 509
Countries citing papers authored by Douglas Colby
This map shows the geographic impact of Douglas Colby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Colby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Colby more than expected).
Fields of papers citing papers by Douglas Colby
This network shows the impact of papers produced by Douglas Colby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Colby. The network helps show where Douglas Colby may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Colby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 6 | |
| 3 | 2019 | 16 | |
| 4 | 2018 | 19 | |
| 5 | 2017 | 14 | |
| 6 | 2016 | 8 | |
| 7 | 2015 | 44 | |
| 8 | 2013 | 138 | |
| 9 | 2013 | 92 | |
| 10 | 2012 | 99 | |
| 11 | 2012 | 252 | |
| 12 | 2009 | 12 | |
| 13 | 2008 | 77 | |
| 14 | Nanog safeguards pluripotency and mediates germline development Hit paper breakdown → | 2007 | 1120 |
| 15 | 2006 | 11 | |
| 16 | Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells Hit paper breakdown → | 2003 | 2519 |
| 17 | As the Curtain Rises: On Contemporary British Drama 1966-1976 | 1978 | 0 |
About Douglas Colby
Douglas Colby is a scholar working on Aging, Molecular Biology, Visual Arts and Performing Arts, Philosophy and Biomedical Engineering, having authored 17 papers that have together received 4.4k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (14 papers), CRISPR and Genetic Engineering (14 papers), Renal and related cancers (4 papers), Epigenetics and DNA Methylation (3 papers), 3D Printing in Biomedical Research (3 papers), Theatre and Performance Studies (1 paper), Tissue Engineering and Regenerative Medicine (1 paper) and Cultural Studies and Interdisciplinary Research (1 paper). The work is most often cited by research in Molecular Biology (4.1k citations), Aging (58 citations), Genetics (248 citations), Developmental Neuroscience (80 citations) and Genetics (509 citations). Douglas Colby has collaborated with scholars based in United Kingdom, Singapore and Japan. Frequent co-authors include Ian Chambers, Morag Robertson, Jennifer Nichols, Austin Smith, Susan Tweedie, Sonia Lee, Bianca Nijmeijer, Ken Jones, Lars Grotewold and Jan Vrána. Their work appears in journals such as The EMBO Journal, Cell stem cell, Biochemical Journal, Life Science Alliance and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.